secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2026-07-29T20:21:44+00:00
Accession:  0001493152-26-035196
Event type: m_and_a
Sentiment:  positive
Materiality: 1.00
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiMedx to acquire Sanara MedTech for $35/share in cash and stock, ~$350M enterprise value
--------------------------------------------------------------------------------

- Sanara shareholders to receive $33 cash plus 0.4735 MiMedx shares per share, valued at $35 total.
- Total enterprise value approximately $350 million; transaction expected to close by July 2027.
- Over $20 million in anticipated annual run-rate cost synergies post-close.
- Stockholders holding ~38.9% of Sanara shares have agreed to vote in favor of the merger.
- Sanara will become a wholly-owned subsidiary of MiMedx; Sanara stock to be delisted from Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315226035196/0001493152-26-035196-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315226035196/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-035196

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer